pyrosequencing

焦磷酸测序
  • 文章类型: Journal Article
    寻找骨质疏松症(OP)的分子标记,基于对骨细胞和外周血细胞中差异脱氧核糖核酸(DNA)甲基化的分析,有望在疾病的早期诊断和靶向治疗领域发展。Runt相关转录因子2(RUNX2)基因是骨代谢的关键基因之一,这在寻找与发生OP风险相关的表观遗传特征和畸变方面很有意义。基于焦磷酸测序,对来自俄罗斯伏尔加河-乌拉尔地区50岁以上俄罗斯种族的男性和女性外周血细胞池中的RUNX2甲基化谱进行了分析.评估了RUNX2基因的三个CpG位点中的DNA甲基化水平,并在男性的所有三个研究CpG位点(U=746.5,p=0.004;U=784,p=0.01;U=788.5,p=0.01)中发现了统计学意义上的低甲基化。在一般样本中,第一个CpG位点的关联得到保留(U=2561,p=0.0001766).结果是首次获得的,表明在OP患者中存在RUNX2的潜在新表观遗传特征。
    The search for the molecular markers of osteoporosis (OP), based on the analysis of differential deoxyribonucleic acid (DNA) methylation in bone cells and peripheral blood cells, is promising for developments in the field of the early diagnosis and targeted therapy of the disease. The Runt-related transcription factor 2 (RUNX2) gene is one of the key genes of bone metabolism, which is of interest in the search for epigenetic signatures and aberrations associated with the risk of developing OP. Based on pyrosequencing, the analysis of the RUNX2 methylation profile from a pool of peripheral blood cells in men and women over 50 years of age of Russian ethnicity from the Volga-Ural region of Russia was carried out. The level of DNA methylation in three CpG sites of the RUNX2 gene was assessed and statistically significant hypomethylation was revealed in all three studied CpG sites in men (U = 746.5, p = 0.004; U = 784, p = 0.01; U = 788.5, p = 0.01, respectively) and in one CpG site in women (U = 537, p = 0.03) with primary OP compared with control. In the general sample, associations were preserved for the first CpG site (U = 2561, p = 0.0001766). The results were obtained for the first time and indicate the existence of potentially new epigenetic signatures of RUNX2 in individuals with OP.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    尽管鸟类的微生物群多样性与其他动物相似,缺乏对非驯化鸟类肠道微生物多样性的研究。这项研究旨在通过分析两种重要的猎鸟物种肠道中存在的细菌群落来解决这一知识差距,环颈野鸡(Phasianuscolchicus)和绿色野鸡(Phasianusversicolor)了解这些物种的肠道微生物多样性。使用合并的粪便样品研究了来自两个不同物种的10只野鸡的肠道微生物组。我们在带有Mothur和SILVA数据库的IonS5XL系统下一代测序上使用16SrRNA基因测序进行分类。在肠道微生物组中平均检测到141个不同的操作分类单位。对微生物分类的分析表明,在两种野鸡中都存在191个属,属于12个不同的门。Alpha多样性指数显示,与杂色疟原虫相比,秋水疟原虫在芽孢杆菌微生物群落中的流行率最高。Alpha多样性指数表明,colchicus具有更多样化的群落,而versicolor具有更大的进化谱系多样性。而两个物种的物种丰富度和样本包容性水平相似。这些发现可能对野鸡的健康和福祉有影响,作为其细菌多样性的参考。此外,它们为未来的研究和保护工作提供了基线,旨在改善这些和可能的其他鸟类的健康和福祉。
    Despite the diversity of microbiota in birds is similar to that of other animals, there is a lack of research on the gut microbial diversity of nondomesticated bird species. This study aims to address this gap in knowledge by analyzing the bacterial communities present in the gut of two important game bird species, the Ring-necked pheasant (Phasianus colchicus) and the Green pheasant (Phasianus versicolor) to understand the gut microbial diversity of these species. The gut microbiome of 10 individual pheasants from two different species was studied using pooled fecal samples. We used 16S rRNA gene sequencing on the Ion S5 XL System next-generation sequencing with Mothur and SILVA Database for taxonomic division. An average of 141 different operational taxonomic units were detected in the gut microbiome. Analysis of microbial classification revealed the presence of 191 genera belonging to 12 different phyla in both pheasants. Alpha diversity indices revealed that P. colchicus exhibited most prevalence firmicutes with bacillus species microbial community than P. versicolor. Alpha diversity indices indicated that P. colchicus had a more diverse community and P. versicolor had a greater diversity of evolutionary lineages, while both species had similar levels of species richness and sample inclusiveness. These findings may have implications for the health and well-being of pheasants, serving as a reference for their bacterial diversity. Additionally, they provide a baseline for future research and conservation efforts aimed at improving the health and well-being of these and possibly other avian species.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:我们研究足月低出生体重(TLBW)新生儿的全基因组DNA甲基化(DNAm)模式。方法:在发现阶段,我们使用EPIC850kBeadChip阵列测定了32个样品(TLBW/对照:16/16)。在复制阶段期间使用靶向焦磷酸测序对60个样品(TLBW/对照:28/32)中的靶向焦磷酸测序。结果:850K阵列鉴定了TLBW相关的144个差异甲基化位置(DMPs)和149个DMRs。近77%的DMP表现出低甲基化,位于公海和基因体区域。KEGG中最显著的富集途径是鞘脂代谢(hsa00600),与该途径相关的基因GALC和SGMS1均显示低甲基化。结论:我们的分析提供了TLBW全基因组DNAm改变的证据。需要进一步的研究来阐明这些DNAm变化的功能意义。
    这项研究观察了怀孕37周后出生但体重不足2500克的婴儿的DNA。我们发现这些婴儿的DNA甲基化水平较低,这可能会改变他们的身体处理脂肪的方式。
    Aim: We investigate the genome-wide DNA methylation (DNAm) patterns of term low birth weight (TLBW) neonates. Methods: In the discovery phase, we assayed 32 samples (TLBW/control:16/16) using the EPIC 850k BeadChip Array. Targeted pyrosequencing of in 60 samples (TLBW/control:28/32) using targeted pyrosequencing during the replication phase. Results: The 850K array identified TLBW-associated 144 differentially methylated positions (DMPs) and 149 DMRs. Nearly 77% DMPs exhibited hypomethylation, located in the opensea and gene body regions. The most significantly enriched pathway in KEGG is sphingolipid metabolism (hsa00600), and the genes GALC and SGMS1 related to this pathway both show hypomethylation. Conclusion: Our analysis provides evidence of genome-wide DNAm alterations in TLBW. Further investigations are needed to elucidate the functional significance of these DNAm changes.
    This study looked at the DNA of babies born after 37 weeks of pregnancy but weighing less than 2500 grams. We found that these babies had lower levels of DNA methylation, which might change how their bodies handle fats.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    高分辨率解链(HRM)是一种用于靶向DNA甲基化分析的经济高效的工具。HRM产生PCR产物中所有CpG的平均甲基化状态。此外,它提供了甲基化模式的信息,例如,单等位基因甲基化的发生。HRM测定必须通过分析已知甲基化状态的DNA甲基化标准品及其混合物来校准。总的来说,通过经典校准方法确定的DNA甲基化水平,包括归一化间隔之间的整个温度范围,与焦磷酸测序(PSQ)确定的单个CpG的DNA甲基化状态的平均值非常吻合,靶向DNA甲基化分析的黄金标准。然而,经典的校准方法导致高度不准确的结果样品与异质DNA甲基化,因为它们导致更复杂的熔解曲线,与DNA标准品及其混合物相比,它们的形状不同。这里,我们提出了一种新颖的校准方法,即,温度校准。通过温度校准,获得随温度变化的甲基化曲线,这有助于找到最佳校准范围,从而提高人力资源管理数据的准确性,特别是对于异质DNA甲基化。为了解释原理并展示新颖校准方法的潜力,我们选择了MGMT的启动子和两个增强子,编码修复蛋白MGMT的基因。
    High-resolution melting (HRM) is a cost-efficient tool for targeted DNA methylation analysis. HRM yields the average methylation status across all CpGs in PCR products. Moreover, it provides information on the methylation pattern, e.g., the occurrence of monoallelic methylation. HRM assays have to be calibrated by analyzing DNA methylation standards of known methylation status and mixtures thereof. In general, DNA methylation levels determined by the classical calibration approach, including the whole temperature range in between normalization intervals, are in good agreement with the mean of the DNA methylation status of individual CpGs determined by pyrosequencing (PSQ), the gold standard of targeted DNA methylation analysis. However, the classical calibration approach leads to highly inaccurate results for samples with heterogeneous DNA methylation since they result in more complex melt curves, differing in their shape compared to those of DNA standards and mixtures thereof. Here, we present a novel calibration approach, i.e., temperature-wise calibration. By temperature-wise calibration, methylation profiles over temperature are obtained, which help in finding the optimal calibration range and thus increase the accuracy of HRM data, particularly for heterogeneous DNA methylation. For explaining the principle and demonstrating the potential of the novel calibration approach, we selected the promoter and two enhancers of MGMT, a gene encoding the repair protein MGMT.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:确定1型糖尿病(T1DM)儿童中与糖尿病视网膜病变(DR)发展相关的差异甲基化位点(DMS)及其相应基因。
    方法:本研究包括两项调查。共有40名T1DM儿童被纳入第一次调查。因为没有参与者有DR,视网膜变薄被用作DR的替代指标。黄斑区视网膜厚度最低的25%参与者被纳入病例组,其他人是控制者.通过Illumina甲基化850K阵列BeadChip测定评估DNA甲基化状态,并对病例组和对照组进行比较。确定了四种在糖尿病中具有潜在作用的DMS。第二项调查包括27名T1DM儿童,其中四个有DR。通过焦磷酸测序在有和没有DR的参与者之间比较了由850K鉴定的四个DMS的甲基化模式。
    结果:在第一次调查中,与对照组相比,850K阵列在病例组中显示出751个显着和差异甲基化的位点(|Δβ|>0.1和Adj。P<0.05),其中328个被确定为具有Adj的意义。P<0.01。其中,相对于对照组,病例组中319个CpG位点被高甲基化,432个CpG位点被低甲基化。焦磷酸测序揭示了转录延伸调节因子1样(TCERG1L,cg07684215)基因在4例T1DM合并DR患儿中呈高甲基化(P=0.018),这与第一次调查的结果一致。其他三个DMS(cg26389052,cg25192647和cg05413694)的甲基化状态在有和没有DR的参与者之间没有差异(均P>0.05)。
    结论:TCERG1L基因的高甲基化是中国T1DM儿童发生DR的危险因素。
    OBJECTIVE: To identify the differential methylation sites (DMS) and their according genes associated with diabetic retinopathy (DR) development in type 1 diabetes (T1DM) children.
    METHODS: This study consists of two surveys. A total of 40 T1DM children was included in the first survey. Because no participant has DR, retina thinning was used as a surrogate indicator for DR. The lowest 25% participants with the thinnest macular retinal thickness were included into the case group, and the others were controls. The DNA methylation status was assessed by the Illumina methylation 850K array BeadChip assay, and compared between the case and control groups. Four DMS with a potential role in diabetes were identified. The second survey included 27 T1DM children, among which four had DR. The methylation patterns of the four DMS identified by 850K were compared between participants with and without DR by pyrosequencing.
    RESULTS: In the first survey, the 850K array revealed 751 sites significantly and differentially methylated in the case group comparing with the controls (|Δβ|>0.1 and Adj.P<0.05), and 328 of these were identified with a significance of Adj.P<0.01. Among these, 319 CpG sites were hypermethylated and 432 were hypomethylated in the case group relative to the controls. Pyrosequencing revealed that the transcription elongation regulator 1 like (TCERG1L, cg07684215) gene was hypermethylated in the four T1DM children with DR (P=0.018), which was consistent with the result from the first survey. The methylation status of the other three DMS (cg26389052, cg25192647, and cg05413694) showed no difference (all P>0.05) between participants with and without DR.
    CONCLUSIONS: The hypermethylation of the TCERG1L gene is a risk factor for DR development in Chinese children with T1DM.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    年龄预测是法医学的一个重要方面,可以为识别提供有价值的见解。近年来,已经对基于DNA甲基化的年龄预测进行了广泛的研究,大量研究表明,DNA甲基化是预测年龄的可靠生物标志物。然而,几乎所有基于DNA甲基化的年龄预测研究都集中在常染色体中与年龄相关的CpG位点,集中在单一来源的DNA样本上。混合样品,尤其是男女混合样本,在法医案件中很常见。Y-STRs和Y-SNPs的应用可以为男性个体在男女混合物中的遗传分型提供线索。但是他们不能提供男性的年龄信息。对Y染色体DNA甲基化的研究可以解决这个问题。在这项研究中,我们在Y染色体上确定了5个与年龄相关的CpG位点(Y-CpGs),并使用焦磷酸测序结合支持向量机算法建立了男性特定年龄预测模型.模型的平均绝对偏差在训练集中为5.50年,在测试集中为6.74年。当我们用男性血液样本来预测年龄时,预测年龄和实际年龄之间的偏差为1.18岁。然后,我们以1:1、1:5、1:10和1:50的比例混合男性和女性的基因组DNA,混合物中男性的预测年龄和实际年龄之间的偏差范围为1.16-1.74岁。此外,在同一样本中,血迹和血液的甲基化值没有显着差异,这表明我们的模型也适用于血迹样本。总的来说,我们的研究结果表明,利用Y染色体DNA甲基化进行年龄预测在法医学中具有潜在的应用价值,对预测男女混合中男性的年龄有很大帮助.此外,这项工作为今后研究Y-CpG与年龄相关的应用奠定了基础。
    Age prediction is an important aspect of forensic science that offers valuable insight into identification. In recent years, extensive studies have been conducted on age prediction based on DNA methylation, and numerous studies have demonstrated that DNA methylation is a reliable biomarker for age prediction. However, almost all studies on age prediction based on DNA methylation have focused on age-related CpG sites in autosomes, which are concentrated on single-source DNA samples. Mixed samples, especially male-female mixed samples, are common in forensic casework. The application of Y-STRs and Y-SNPs can provide clues for the genetic typing of male individuals in male-female mixtures, but they cannot provide the age information of male individuals. Studies on Y-chromosome DNA methylation can address this issue. In this study, we identified five age-related CpG sites on the Y chromosome (Y-CpGs) and developed a male-specific age prediction model using pyrosequencing combined with a support vector machine algorithm. The mean absolute deviation of the model was 5.50 years in the training set and 6.74 years in the testing set. When we used a male blood sample to predict age, the deviation between the predicted and chronological age was 1.18 years. Then, we mixed the genomic DNA of the male and a female at ratios of 1:1, 1:5, 1:10, and 1:50, the range of deviation between the predicted and chronological age of the male in the mixture was 1.16-1.74 years. In addition, there was no significant difference between the methylation values of bloodstains and blood in the same sample, which indicates that our model is also suitable for bloodstain samples. Overall, our results show that age prediction using DNA methylation of the Y chromosome has potential applications in forensic science and can be of great help in predicting the age of males in male-female mixtures. Furthermore, this work lays the foundation for future research on age-related applications of Y-CpGs.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    自身免疫性甲状腺疾病(AITDs)的预后,包括桥本病(HD)和格雷夫斯病(GD),很难预测。DNA甲基化调节免疫介导因子的基因表达。白细胞介素(IL)-10是下调由Th1细胞产生的炎性细胞因子的Th2细胞因子。阐明IL10基因甲基化在AITD预后中的作用,我们使用焦磷酸测序评估了IL10启动子中两个CpG位点的甲基化水平.在GD患者中,IL10基因的-185CpG位点的甲基化水平与年龄和GD难处理性有关。此外,IL10-592A/C多态性的C携带者与-185CpG位点的低甲基化水平有关。IL10基因的IL10-185CpG位点的甲基化水平与GD的难处理性有关,在具有IL10-592A/C多态性的C等位基因的个体中,甲基化水平较低。
    The prognosis of autoimmune thyroid diseases (AITDs), including Hashimoto\'s disease (HD) and Graves\' disease (GD), is difficult to predict. DNA methylation regulates gene expression of immune mediating factors. Interleukin (IL)-10 is a Th2 cytokine that downregulates inflammatory cytokines produced by Th1 cells. To clarify the role of methylation of the IL10 gene in the prognosis of AITD, we evaluated the methylation levels of two CpG sites in the IL10 promoter using pyrosequencing. The methylation levels of the -185 CpG site of the IL10 gene were related to age and GD intractability in GD patients. Furthermore, the C carrier of the IL10-592 A/C polymorphism was related to low methylation levels of the -185 CpG site. The methylation levels of the IL10-185 CpG site of the IL10 gene were related to the intractability of GD and were lower in individuals with the C allele of the IL10-592 A/C polymorphism.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    通过对犯罪者的描述做出贡献,从痕迹样本中估算出的人类年龄可能会在警方调查的早期提供重要线索。几种分子生物标志物可用于估计实际年龄,目前,DNA甲基化模式是最有前途的。在这项研究中,5个法医遗传实验室对用于年龄估计的QIAGEN年龄方案进行了测试.该测定包括亚硫酸氢盐处理提取的DNA,5个CpG基因座的扩增(在ELOVL2,C1orf132,TRIM59,KLF14和FHL2的基因中),和使用PyroMarkQ48平台对扩增子进行测序。分析了49名年龄在18至64岁之间的个体的血液样本以及阴性和甲基化对照。应用现有的年龄估计模型来显示参考数据集中3.62年的平均绝对偏差。
    年龄确定作为调查期间的情报工具可以成为法医遗传学的强大工具。在这项研究中,5个实验室检测了49个样本,得到的平均绝对偏差为3.62年.在PyroMarkQ48平台上分析五个标记。
    Human age estimation from trace samples may give important leads early in a police investigation by contributing to the description of the perpetrator. Several molecular biomarkers are available for the estimation of chronological age, and currently, DNA methylation patterns are the most promising. In this study, a QIAGEN age protocol for age estimation was tested by five forensic genetic laboratories. The assay comprised bisulfite treatment of the extracted DNA, amplification of five CpG loci (in the genes of ELOVL2, C1orf132, TRIM59, KLF14, and FHL2), and sequencing of the amplicons using the PyroMark Q48 platform. Blood samples from 49 individuals with ages ranging from 18 to 64 years as well as negative and methylation controls were analyzed. An existing age estimation model was applied to display a mean absolute deviation of 3.62 years within the reference data set.
    UNASSIGNED: Age determination as an intelligence tool during investigations can be a powerful tool in forensic genetics.In this study, five laboratories ran 49 samples and obtained a mean absolute deviation of 3.62 years.Five markers were analyzed on a PyroMark Q48 platform.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    低危骨髓增生异常肿瘤(LR-MDS)占MDS的大部分。尽管预后良好,一些患者仍有快速进展的风险.我们旨在使用下一代测序(NGS)定义LR-MDS的突变谱,Sanger测序(SSeq),和焦磷酸测序。
    来自5个主要LR-MDS(SF3B1,U2AF1,SRSF2,ZRSR2,TET2,ASXL1,DNMT3A的67个外显子,TP53和RUNX1基因)进行NGS。接下来,进行了一项基因组研究,以测试在更大的一组LR-MDS患者中是否存在已识别的DNA序列变异(25骨髓[BM],3唾液[SAL],和一份外周血[PB]样本/s)。进行SSeq(所有选择的DNA序列变体)和焦磷酸测序(9个选择的DNA序列变体)。
    下一代测序结果确定了7个基因中的13个DNA序列变体,在6个基因中包含8个突变(ASXL1、DNMT3A、RUNX1,SF3B1,TET2,ZRSR2)在LR-MDS中。使用SSeq和焦磷酸测序在扩增的LR-MDS组中检测到8种DNA变体的存在。在LR-MDS进展期间观察到突变采集。四名LR-MDS和一名急性髓性白血病骨髓增生异常相关患者表现出至少一种突变。ASXL1和SF3B1改变最常见(2例)。在BM中检测到的五个DNA序列变体(患者:9,13)也存在于SAL中。
    我们建议在诊断和怀疑疾病进展时使用NGS来确定LR-MDS突变谱。此外,PB和SAL分子检测是监测进展风险较高的LR-MDS的有用工具。然而,结果需要在更大的群体中确认。
    UNASSIGNED: Lower-risk myelodysplastic neoplasms (LR-MDS) comprise the majority of MDS. Despite favourable prognoses, some patients remain at risk of rapid progression. We aimed to define the mutational profile of LR-MDS using next-generation sequencing (NGS), Sanger Sequencing (SSeq), and pyrosequencing.
    UNASSIGNED: Samples from 5 primary LR-MDS (67 exons of SF3B1, U2AF1, SRSF2, ZRSR2, TET2, ASXL1, DNMT3A, TP53, and RUNX1 genes) were subjected to NGS. Next, a genomic study was performed to test for the presence of identified DNA sequence variants on a larger group of LR-MDS patients (25 bone marrow [BM], 3 saliva [SAL], and one peripheral blood [PB] sample/s). Both SSeq (all selected DNA sequence variants) and pyrosequencing (9 selected DNA sequence variants) were performed.
    UNASSIGNED: Next-generation sequencing results identified 13 DNA sequence variants in 7 genes, comprising 8 mutations in 6 genes (ASXL1, DNMT3A, RUNX1, SF3B1, TET2, ZRSR2) in LR-MDS. The presence of 8 DNA variants was detected in the expanded LR-MDS group using SSeq and pyrosequencing. Mutation acquisition was observed during LR-MDS progression. Four LR-MDS and one acute myeloid leukaemia myelodysplasia-related patient exhibited the presence of at least one mutation. ASXL1 and SF3B1 alterations were most commonly observed (2 patients). Five DNA sequence variants detected in BM (patients: 9, 13) were also present in SAL.
    UNASSIGNED: We suggest using NGS to determine the LR-MDS mutational profile at diagnosis and suspicion of disease progression. Moreover, PB and SAL molecular testing represent useful tools for monitoring LR-MDS at higher risk of progression. However, the results need to be confirmed in a larger group.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在法医案件工作中,必须从生物标本中建立DNA图谱,并准确识别特定的体液来源。为了实现这一点,DNA甲基化标记已经被开发用于血液的分化,精液,阴道上皮分泌物,还有唾液样本.唾液,或者称为口服液,因其异质的细胞组成而被认可,以上皮混合物为特征,白细胞,和细菌细胞。因此,我们的研究揭示了甲基化百分比的差异,这些差异与收集唾液样本的方法相关.为了研究这些概念,我们仔细检查了位于BCAS4内或附近的四个CpG标记,SLC12A8,SOX2OT,和FAM43A基因。随后,我们设计了基于生物信息转化的参考序列的引物,这些标记,并通过检查二聚体和发夹形成严格评估其质量,熔化温度,和特异性。这些基因座基于口腔拭子或唾液收集被鉴定为唾液标记物。然而,很少或没有进行研究来探索不同收集方法之间的甲基化差异。对于这项研究,颊,唇,舌头,吐口水,从20个人(N=100)收集鼻拭子。模拟法医样本,其中包括口香糖(N=10)和香烟(N=10),也进行了测试。提取DNA,亚硫酸氢盐转化,然后使用内部设计的检测方法进行扩增,并进行了高温测序。甲基化水平与其他体液(精液,血,阴道上皮,和月经血[N=32])。共608次焦磷酸测序结果表明,采样位置和采集方法可以极大地影响甲基化水平,强调在开发表观遗传标记时检查体液的多种收集/沉积方法的重要性。
    In the context of forensic casework, it is imperative to both establish a DNA profile from biological specimens and accurately identify the specific bodily fluid source. To achieve this, DNA methylation markers have been developed for the differentiation of blood, semen, vaginal epithelial secretions, and saliva samples. Saliva, alternatively referred to as oral fluid, is recognized for its heterogeneous cellular composition, characterized by a mixture of epithelial, leukocytic, and bacterial cells. Consequently, our research has revealed variations in methylation percentages that correlate with the method employed for collecting saliva samples. To investigate these concepts, we scrutinized four CpG markers situated within or in proximity to the BCAS4, SLC12A8, SOX2OT, and FAM43A genes. Subsequently, we designed primers based on bioinformatically transformed reference sequences for these markers and rigorously assessed their quality by examining dimer and hairpin formation, melting temperature, and specificity. These loci were identified as saliva markers based on either buccal swabs or spit collection. Yet, there has been minimal or no research conducted to explore the variations in methylation between different collection methods. For this study, buccal, lip, tongue, spit, and nasal swabs were collected from 20 individuals (N = 100). Mock forensic samples, which include chewing gum (N = 10) and cigarettes (N = 10), were also tested. DNA was extracted, bisulfite converted, then amplified using in-house designed assays, and pyrosequenced. The methylation levels were compared to other body fluids (semen, blood, vaginal epithelia, and menstrual blood [N = 32]). A total of 608 pyrosequencing results demonstrated that sampling location and collection method can greatly influence the level of methylation, highlighting the importance of examining multiple collection/deposition methods for body fluids when developing epigenetic markers.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号